Skip to main content
Top
Published in: Journal of Cancer Education 2/2024

26-12-2023

Evaluating the Educational Value of Cancer Registries — a Systematic Review and Thematic Analysis

Authors: James Lin, Hugo C. Temperley, Kirsten Larkins, Caitlin Waters, Kit Loong Chong, Jack Maida, David Proud, Adele Burgess, Alexander Heriot, Philip Smart, Helen Mohan

Published in: Journal of Cancer Education | Issue 2/2024

Login to get access

Abstract

Cancer registries encompass a broad array of functions that underpin cancer control efforts. Despite education being fundamental to improving patient outcomes, little is known regarding the educational value of cancer registries. This review will evaluate the educational value of cancer registries for key stakeholders as reported within published literature and identify opportunities for enhancing their educational value. Four databases (Ovid Medline, Embase, CINAHL and Web of Science) were searched using a predefined search strategy in keeping with the PRISMA statement. Data was extracted and synthesised in narrative format. Themes and frequency of discussion of educational content were explored using thematic content analysis. From 952 titles, ten eligible studies were identified, highlighting six stakeholder groups. Educational outcomes were identified relating to clinicians (6/10), researchers (5/10), patients (4/10), public health organisations (3/10), medical students (1/10) and the public (1/10). Cancer registries were found to educationally benefit key stakeholders despite educational value not being a key focus of any study. Deliberate efforts to harness the educational value of cancer registries should be considered to enable data-driven quality improvement, with the vast amount of data promising ample educational benefit.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed
4.
go back to reference Armstrong BK (1992) The role of the cancer registry in cancer control. Cancer Causes Control 3(6):569–579CrossRefPubMed Armstrong BK (1992) The role of the cancer registry in cancer control. Cancer Causes Control 3(6):569–579CrossRefPubMed
5.
go back to reference Platz EA (2017) Reducing cancer burden in the population: an overview of epidemiologic evidence to support policies, systems, and environmental changes. Epidemiol Rev 39(1):1–10CrossRefPubMedPubMedCentral Platz EA (2017) Reducing cancer burden in the population: an overview of epidemiologic evidence to support policies, systems, and environmental changes. Epidemiol Rev 39(1):1–10CrossRefPubMedPubMedCentral
6.
go back to reference Pop B, Fetica B, Blaga ML, Trifa AP, Achimas-Cadariu P, Vlad CI et al (2019) The role of medical registries, potential applications and limitations. Med Pharm Rep 92(1):7–14PubMedPubMedCentral Pop B, Fetica B, Blaga ML, Trifa AP, Achimas-Cadariu P, Vlad CI et al (2019) The role of medical registries, potential applications and limitations. Med Pharm Rep 92(1):7–14PubMedPubMedCentral
7.
go back to reference Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138CrossRefPubMedPubMedCentral Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138CrossRefPubMedPubMedCentral
8.
go back to reference Das A (2009) Cancer registry databases: an overview of techniques of statistical analysis and impact on cancer epidemiology. Methods Mol Biol 471:31–49CrossRefPubMed Das A (2009) Cancer registry databases: an overview of techniques of statistical analysis and impact on cancer epidemiology. Methods Mol Biol 471:31–49CrossRefPubMed
9.
go back to reference Parkin DM, Bray F (2009) Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 45(5):756–764CrossRefPubMed Parkin DM, Bray F (2009) Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 45(5):756–764CrossRefPubMed
10.
go back to reference Bray F, Parkin DM (2009) Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 45(5):747–755CrossRefPubMed Bray F, Parkin DM (2009) Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 45(5):747–755CrossRefPubMed
12.
go back to reference Ingelfinger JR, Drazen JM (2004) Registry research and medical privacy. N Engl J Med 350(14):1452–1453CrossRefPubMed Ingelfinger JR, Drazen JM (2004) Registry research and medical privacy. N Engl J Med 350(14):1452–1453CrossRefPubMed
16.
go back to reference Wormald JS, Oberai T, Branford-White H, Johnson LJ (2020) Design and establishment of a cancer registry: a literature review. ANZ J Surg 90(7-8):1277–1282CrossRefPubMed Wormald JS, Oberai T, Branford-White H, Johnson LJ (2020) Design and establishment of a cancer registry: a literature review. ANZ J Surg 90(7-8):1277–1282CrossRefPubMed
17.
go back to reference Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6(8):603–612CrossRefPubMed Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6(8):603–612CrossRefPubMed
18.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372:n71CrossRefPubMedPubMedCentral Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372:n71CrossRefPubMedPubMedCentral
20.
go back to reference Cook DA, Reed DA (2015) Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med 90(8):1067–1076CrossRefPubMed Cook DA, Reed DA (2015) Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med 90(8):1067–1076CrossRefPubMed
21.
go back to reference Kiger ME, Varpio L (2020) Thematic analysis of qualitative data: AMEE Guide No. 131. Med Teach 42(8):846–854CrossRefPubMed Kiger ME, Varpio L (2020) Thematic analysis of qualitative data: AMEE Guide No. 131. Med Teach 42(8):846–854CrossRefPubMed
22.
go back to reference Jiagge E, Bensenhaver JM, Oppong JK, Awuah B, Newman LA (2015) Global surgical oncology disease burden: addressing disparities via global surgery initiatives: the University of Michigan International Breast Cancer Registry. Ann Surg Oncol 22(3):734–740CrossRefPubMed Jiagge E, Bensenhaver JM, Oppong JK, Awuah B, Newman LA (2015) Global surgical oncology disease burden: addressing disparities via global surgery initiatives: the University of Michigan International Breast Cancer Registry. Ann Surg Oncol 22(3):734–740CrossRefPubMed
23.
go back to reference Chen AM, Kupelian PA, Wang PC, Steinberg ML (2018) Development of a radiation oncology-specific prospective data registry for research and quality improvement: a clinical workflow-based solution. JCO Clin Cancer Inform 2:1–9CrossRefPubMed Chen AM, Kupelian PA, Wang PC, Steinberg ML (2018) Development of a radiation oncology-specific prospective data registry for research and quality improvement: a clinical workflow-based solution. JCO Clin Cancer Inform 2:1–9CrossRefPubMed
24.
go back to reference Auffenberg GB, Ghani KR, Ramani S, Usoro E, Denton B, Rogers C et al (2019) askMUSIC: Leveraging a clinical registry to develop a new machine learning model to inform patients of prostate cancer treatments chosen by similar men. Eur Urol 75(6):901–907CrossRefPubMed Auffenberg GB, Ghani KR, Ramani S, Usoro E, Denton B, Rogers C et al (2019) askMUSIC: Leveraging a clinical registry to develop a new machine learning model to inform patients of prostate cancer treatments chosen by similar men. Eur Urol 75(6):901–907CrossRefPubMed
25.
go back to reference Joishy SK, Driscol JC (1989) The ailments of cancer registries: a proposal for remedial education. J Cancer Educ 4(1):17–31CrossRefPubMed Joishy SK, Driscol JC (1989) The ailments of cancer registries: a proposal for remedial education. J Cancer Educ 4(1):17–31CrossRefPubMed
26.
go back to reference Struth D (2017) Oncology Qualified Clinical Data Registry: a patient-centered, symptom-focused framework to guide quality improvement. Clin J Oncol Nurs 21(6):755–757CrossRefPubMed Struth D (2017) Oncology Qualified Clinical Data Registry: a patient-centered, symptom-focused framework to guide quality improvement. Clin J Oncol Nurs 21(6):755–757CrossRefPubMed
27.
go back to reference Burton RC (2002) Cancer control in Australia: into the 21(st) Century. Jpn J Clin Oncol 32(Suppl):S3–S9CrossRefPubMed Burton RC (2002) Cancer control in Australia: into the 21(st) Century. Jpn J Clin Oncol 32(Suppl):S3–S9CrossRefPubMed
28.
go back to reference MacCallum C, Skandarajah A, Gibbs P, Hayes I (2018) The value of clinical colorectal cancer registries in colorectal cancer research: a systematic review. JAMA Surg 153(9):841–849CrossRefPubMed MacCallum C, Skandarajah A, Gibbs P, Hayes I (2018) The value of clinical colorectal cancer registries in colorectal cancer research: a systematic review. JAMA Surg 153(9):841–849CrossRefPubMed
29.
go back to reference Meiser B, Monnik M, Austin R, Nichols C, Cops E, Salmon L et al (2022) Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study. J Community Genet 13(1):59–73CrossRefPubMed Meiser B, Monnik M, Austin R, Nichols C, Cops E, Salmon L et al (2022) Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study. J Community Genet 13(1):59–73CrossRefPubMed
30.
go back to reference Rothenmund H, Singh H, Candas B, Chodirker BN, Serfas K, Aronson M et al (2013) Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011. Curr Oncol 20(5):273–278CrossRefPubMedPubMedCentral Rothenmund H, Singh H, Candas B, Chodirker BN, Serfas K, Aronson M et al (2013) Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011. Curr Oncol 20(5):273–278CrossRefPubMedPubMedCentral
31.
Metadata
Title
Evaluating the Educational Value of Cancer Registries — a Systematic Review and Thematic Analysis
Authors
James Lin
Hugo C. Temperley
Kirsten Larkins
Caitlin Waters
Kit Loong Chong
Jack Maida
David Proud
Adele Burgess
Alexander Heriot
Philip Smart
Helen Mohan
Publication date
26-12-2023
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 2/2024
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-023-02394-6

Other articles of this Issue 2/2024

Journal of Cancer Education 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine